http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2342069-T4
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_09cf654421401ec2aea00d0a5bfa001e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-708 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-708 |
| filingDate | 2004-09-01^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-01-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0e33a10dea704fe9dccd997dc109c9b |
| publicationDate | 2011-01-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2342069-T4 |
| titleOfInvention | TLR7 LINKS FOR THE TREATMENT OF HEPATITIS C. |
| abstract | The use of a TLR7 ligand for the manufacture of a medicament for the treatment of a hepatitis C virus infection in a patient, in which the TLR7 ligand is selected from <br /> <br /> ** (See formula) ** in which: <br /> <br /> each R1 is H or a substituted or unsubstituted alkyl, alkenyl or alkynyl, which may be interrupted with one or more heteroatoms O, S or N, or a substituted or unsubstituted aryl or heteroaryl; <br /> <br /> R2 is H, OH, SH, halo or a substituted or unsubstituted alkyl, alkenyl or alkynyl, which may be interrupted with one or more heteroatoms O, S or N, or an -O- (alkyl), -O- (aryl), -O- (heteroaryl), -S- (alkyl), -S- (aryl), -S- (heteroaryl), aryl or heteroaryl substituted or unsubstituted; <br /> <br /> R3 is H, OH or SH, or an alkyl, alkenyl, alkynyl, aryl, heteroaryl, -O- (alkyl), -O- (aryl), -O- (heteroaryl), -S- (alkyl), -S- (aryl), -S- (heteroaryl), -NH (alkyl), -NH (aryl), -NH (heteroaryl), -NH (R4) (alkyl ), -NH (R4) (aryl) or -NH (R4) (substituted or unsubstituted heteroaryl), in which R4 is a substituted or unsubstituted alkyl; <br /> <br /> X is O or S; <br /> <br /> Y is H, halo, OH, OR4, SH, SR4 or a substituted or unsubstituted alkyl or aryl; <br /> <br /> Z is H, halo, OH, OR4, SH or SR4; < br /> <br /> or a pharmaceutically acceptable salt, hydrate or stereoisomer thereof or a pharmaceutically acceptable salt or hydrate of said stereoisomer. |
| priorityDate | 2003-09-05^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 1000 of 1746.
| Next Page | Last Page |